My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Alpramil 12.5 mg/125 mg tablets for dogs weighing at least 5 kg



Alfasan Nederland B.VVPA10980/018/002

Main Information

Trade NameAlpramil 12.5 mg/125 mg tablets for dogs weighing at least 5 kg
Active SubstancesMilbemycin oxime for veterinary use
Praziquantel
Dosage FormTablet
Licence HolderAlfasan Nederland B.V
License Holder AddressKuipersweg 9
3449 JA Woerden
Netherlands
Licence NumberVPA10980/018/002

Group Information

ATC CodeQP54AB51 milbemycin oxime, combinations
Therapeutic ClassEndectoparasiticides
SpeciesDogs

Status

License statusAuthorised
Licence Issued14/04/2022
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back
Follow medicine

Print